We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App





Roche Showcases the Future of Diagnostic Solutions at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 11 Apr 2022
Print article
Image: cobas® pulse system (Photo courtesy of Roche Diagnostics)
Image: cobas® pulse system (Photo courtesy of Roche Diagnostics)

Roche Diagnostics (Basel, Switzerland) showcased its next generation diagnostics solutions that deliver fast and accurate results to help clinicians improve patient care and help reduce the healthcare burden at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicines (EUROMEDLAB) in Munich, Germany.

These included the cobas 5800 System that expands access to PCR testing with meaningful and timely results to more patients across the globe, and a new handheld glucose management device, the cobas pulse, powered by the cobas infinity edge suite, that equips healthcare professionals with expanded digital capabilities at the point of care. An evaluation of the recently launched AVENIO Tumour Tissue Comprehensive Genomic Profiling (CGP) Kit for oncology research was also presented. The kit helps expand access to genomic profiling globally, supporting researchers in navigating the complex landscape of cancer research. The findings assess genomic results generated across multiple CGP workflows for variants that are known to cause and drive cancer.

Roche also hosted its very own highly interactive booth, where attendees visited and experienced how the company is helping to improve healthcare. Highlights from the booth included an integrated diagnostics lab and data analytics tools that guide the decision-making process toward optimizing lab operations, customer delivery, and overall lab performance in a targeted and efficient manner. There was also a special interactive area at the booth highlighting Roche’s COVID-19 response. Those unable to attend the congress in person were able to view and engage in the virtual booth via an online portal, with Ro_Bot, a virtual character, as host: Roche EUROMEDLAB 2021. Those joining online were able to follow key sessions via livestream, at no cost. During the congress, Roche also facilitated discussions on key topics in diagnostics today, including three educational workshops.

“Roche is committed to developing innovative solutions that equip healthcare professionals with the tools that allow for earlier diagnosis and more personalized treatment, optimizing patient care and leading to better outcomes,” said Ann Costello, Global Head, Roche Diagnostics Solutions. “We are proud to work in partnership with healthcare professionals across many disease areas and disciplines to enable better healthcare decisions.”

“Lab medicine has always played a key role in healthcare, as proven during the Covid-19 pandemic,” added Moritz Hartmann, Global Head of Roche Information Solutions. “We are working with industry leaders worldwide on digital health solutions to facilitate data-driven decision-making in any setting. This includes labs, clinics and homes with the ultimate goal to improve care for each patient and reduce inefficiencies in healthcare delivery.”

Related Links:
Roche Diagnostics 

New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
Gold Member
Troponin T QC
Troponin T Quality Control
New
Sample Transport Medium
UMMt RevolutioN 2
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Pathology

view channel
Image: Microscopic images showing healthy villi on the left and diseased villi on the right (Photo courtesy of Florian Jaeckle/University of Cambridge)

Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy

Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.